-+ 0.00%
-+ 0.00%
-+ 0.00%

GRIFOLS DOSES FIRST PATIENTS IN TWO PHASE 3 TRIALS TO EXPAND INDICATIONS OF ITS FLAGSHIP IMMUNOGLOBULINS

Reuters·07/16/2026 12:00:02

Please log in to view news